This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1981-1982.
Company Filing History:
Years Active: 1981-1982
Title: Eberhard Schickel: Innovating Diagnostic Solutions in Medicine
Introduction
Eberhard Schickel, a notable inventor based in Selters, Germany, has made significant contributions to the field of medical diagnostics. With a total of two patents, his work primarily focuses on creating innovative solutions that enhance the visualization of the hepatobiliary system and the examination of the reticuloendothelial system (RES).
Latest Patents
Eberhard Schickel's latest patents include a groundbreaking diagnostic agent that utilizes Technetium-99m-labelled (2,4,5-trimethylacetanilido)-iminodiacetate. This agent plays a crucial role in visualizing the hepatobiliary system by containing the active compound in a suitable solvent. Additionally, he has developed processes for the preparation of this diagnostic agent, as well as its intermediate product, chloroacetic acid-(2,4,5-trimethylanilide). His other patent involves a method for preparing a diagnostic agent for scanning the RES, particularly the liver, involving a precise mixture of specific chemical compounds and conditions.
Career Highlights
Eberhard Schickel works at Hoechst Aktiengesellschaft, where he applies his extensive knowledge and skills in the development of innovative diagnostic methods. His work has paved the way for advanced imaging techniques, contributing significantly to medical diagnostics.
Collaborations
Throughout his career, Eberhard has collaborated with fellow researchers Michael Molter and Gerhard Kloss. Together, they have worked on developing cutting-edge solutions that address critical needs in the healthcare sector, enhancing the effectiveness of diagnostic procedures.
Conclusion
Eberhard Schickel stands out as a prominent inventor in the field of medical diagnostics. His innovative patents and collaborative efforts demonstrate his commitment to advancing healthcare technologies and improving patient outcomes.
